ZA967282B - Zwitterionic forms of trovafloxacin. - Google Patents

Zwitterionic forms of trovafloxacin.

Info

Publication number
ZA967282B
ZA967282B ZA9607282A ZA967282A ZA967282B ZA 967282 B ZA967282 B ZA 967282B ZA 9607282 A ZA9607282 A ZA 9607282A ZA 967282 A ZA967282 A ZA 967282A ZA 967282 B ZA967282 B ZA 967282B
Authority
ZA
South Africa
Prior art keywords
trovafloxacin
zwitterionic forms
zwitterionic
forms
Prior art date
Application number
ZA9607282A
Other languages
English (en)
Inventor
Douglas John Meldrum Allen
David Bruning Joseph
Timothy Norris
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA967282B publication Critical patent/ZA967282B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Physical Water Treatments (AREA)
  • Processing Of Solid Wastes (AREA)
ZA9607282A 1995-08-29 1996-08-28 Zwitterionic forms of trovafloxacin. ZA967282B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US297595P 1995-08-29 1995-08-29

Publications (1)

Publication Number Publication Date
ZA967282B true ZA967282B (en) 1998-03-02

Family

ID=21703460

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9607282A ZA967282B (en) 1995-08-29 1996-08-28 Zwitterionic forms of trovafloxacin.

Country Status (30)

Country Link
EP (1) EP0850060A1 (sh)
JP (1) JP3188476B2 (sh)
KR (1) KR100343909B1 (sh)
CN (1) CN1190889A (sh)
AP (1) AP636A (sh)
AR (1) AR003985A1 (sh)
AU (1) AU704115B2 (sh)
BR (1) BR9609998A (sh)
CA (1) CA2229786C (sh)
CO (1) CO4480739A1 (sh)
CZ (1) CZ56698A3 (sh)
DZ (1) DZ2087A1 (sh)
GT (1) GT199600072A (sh)
HR (1) HRP960395B1 (sh)
HU (1) HUP9900170A3 (sh)
IL (1) IL122651A (sh)
MA (1) MA23966A1 (sh)
MY (1) MY113874A (sh)
NO (1) NO309814B1 (sh)
NZ (1) NZ312199A (sh)
OA (1) OA10669A (sh)
PE (1) PE12598A1 (sh)
PL (1) PL325170A1 (sh)
RU (1) RU2144921C1 (sh)
SK (1) SK23898A3 (sh)
TN (1) TNSN96109A1 (sh)
TR (1) TR199800339T1 (sh)
WO (1) WO1997007800A1 (sh)
YU (1) YU48396A (sh)
ZA (1) ZA967282B (sh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
US7019142B2 (en) 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
US6239141B1 (en) * 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids

Also Published As

Publication number Publication date
JPH10511692A (ja) 1998-11-10
KR19990044232A (ko) 1999-06-25
MY113874A (en) 2002-06-29
EP0850060A1 (en) 1998-07-01
AU6367696A (en) 1997-03-19
IL122651A0 (en) 1998-08-16
JP3188476B2 (ja) 2001-07-16
CA2229786A1 (en) 1997-03-06
AR003985A1 (es) 1998-09-30
HUP9900170A3 (en) 1999-11-29
AP636A (en) 1998-04-09
AP9600853A0 (en) 1996-10-31
CO4480739A1 (es) 1997-07-09
NO980862D0 (no) 1998-02-27
MX9801664A (es) 1998-08-30
IL122651A (en) 2000-02-17
WO1997007800A1 (en) 1997-03-06
NO309814B1 (no) 2001-04-02
YU48396A (sh) 1998-12-23
BR9609998A (pt) 1999-07-06
TR199800339T1 (xx) 1998-06-22
OA10669A (en) 2000-11-06
PL325170A1 (en) 1998-07-06
NO980862L (no) 1998-02-27
TNSN96109A1 (fr) 2005-03-15
GT199600072A (es) 1998-02-14
PE12598A1 (es) 1998-03-20
KR100343909B1 (ko) 2003-04-10
MA23966A1 (fr) 1997-04-01
DZ2087A1 (fr) 2002-07-22
HUP9900170A2 (hu) 1999-05-28
HRP960395A2 (en) 1998-06-30
RU2144921C1 (ru) 2000-01-27
AU704115B2 (en) 1999-04-15
CA2229786C (en) 2002-02-19
HRP960395B1 (en) 2001-12-31
CN1190889A (zh) 1998-08-19
NZ312199A (en) 1999-06-29
CZ56698A3 (cs) 1999-02-17
SK23898A3 (en) 1999-05-07

Similar Documents

Publication Publication Date Title
HK1001852A1 (en) Massager.
AU4780596A (en) Hemi-wheeled walker
ZA967315B (en) Biphenylamides.
MX213417B (es) Fenilpiridazinonas.
ZA964468B (en) Triazolylmethyl-cyclopentanols.
ZA961955B (en) Indazolecarboxamides.
ZA969221B (en) Indolealkyl derivatives of benzodioxanmethylamine.
DE69610844D1 (en) Hydroformylierungsverfahren.
ZA965922B (en) Preparation of N-substituted 3-hydroxypyrazoles.
AU6710496A (en) Riser
ZA966603B (en) Therapeutic method.
ZA966399B (en) Endothelin-receptor-antagonists.
ZA967282B (en) Zwitterionic forms of trovafloxacin.
GB9600205D0 (en) Interferometer
ZA966750B (en) Halogenobenzimidazoles.
ZA966933B (en) Endothelin-receptor-antagonists.
GB9602060D0 (en) Combined shower
AU1682395A (en) Speckle depixelator
ZA967314B (en) Carbamoylcarboxamides.
GB9500420D0 (en) Riser assembly
AU4778996A (en) Starting aid
ZA965310B (en) Therapeutic compounds.
GB9509653D0 (en) Walker
HU9501741D0 (en) Walker
PL309092A1 (en) Ultrasonic atomiser